Literature DB >> 12059026

In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents.

Hua Zhang1, Steven H Neau.   

Abstract

The degradative activities of extracellular and cell-associated portions of rat cecal and colonic enzymes, whose activities are comparable to that in the human colon, against five chitosan samples were characterized. The effects of the molecular weight (MW) and degree of deacetylation (DD) of chitosan on its susceptibility to degradation were investigated. In addition, the degradation function of rat bacterial enzymes was compared to that of a commercially available almond emulsin beta-glucosidase that contains a chitinase. The results show that rat bacterial enzymes had the ability to degrade chitosan with extracellular enzymes exhibiting a more profound effect than did cell-associated enzymes. The reaction to bacterial enzymes degradation was dependent on both the MW and DD of the chitosan sample. Those samples with a lower MW and lower DD were more susceptible substrates. A similar degradation function of rat bacterial enzymes and of almond emulsin beta-glucosidase on chitosan was revealed, which indicates that almond emulsin beta-glucosidase might be able to be used as an in vitro enzyme system to predict the large intestinal degradation of chitosan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059026     DOI: 10.1016/s0142-9612(02)00011-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

Review 1.  Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Authors:  Roudayna Diab; Chiraz Jaafar-Maalej; Hatem Fessi; Philippe Maincent
Journal:  AAPS J       Date:  2012-07-06       Impact factor: 4.009

Review 2.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

3.  Influence of porosity and fibre diameter on the degradation of chitosan fibre-mesh scaffolds and cell adhesion.

Authors:  C Cunha-Reis; K TuzlaKoglu; E Baas; Y Yang; A El Haj; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

4.  An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol3.

Authors:  Regine Beeck; Annemarie Dols; Felix Schneider; Dariah-Sohreh Seradj; Julius Krause; Philipp Schick; Werner Weitschies
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

5.  Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.

Authors:  Wycliffe S Omwancha; Rama Mallipeddi; Brenda L Valle; Steven H Neau
Journal:  Int J Pharm       Date:  2012-11-28       Impact factor: 5.875

Review 6.  Advances in Degradable Embolic Microspheres: A State of the Art Review.

Authors:  Jensen Doucet; Lauren Kiri; Kathleen O'Connell; Sharon Kehoe; Robert J Lewandowski; David M Liu; Robert J Abraham; Daniel Boyd
Journal:  J Funct Biomater       Date:  2018-01-26

7.  Cellular delivery of quantum dot-bound hybridization probe for detection of intracellular pre-microRNA using chitosan/poly(γ-glutamic acid) complex as a carrier.

Authors:  Yao Geng; Dajie Lin; Lijia Shao; Feng Yan; Huangxian Ju
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

8.  Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.

Authors:  M J Barea; M J Jenkins; Y S Lee; P Johnson; R H Bridson
Journal:  Int J Biomater       Date:  2012-06-27

Review 9.  Chitosan nanoparticles for oral drug and gene delivery.

Authors:  Katherine Bowman; Kam W Leong
Journal:  Int J Nanomedicine       Date:  2006

10.  Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery.

Authors:  Bipul Nath; Lila Kanta Nath
Journal:  J Pharm (Cairo)       Date:  2012-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.